Cargando...
CMET-07. VISMODEGIB TREATMENT OF INTRACRANIAL INVASION OF BASAL CELL CARCINOMA
BACKGROUND: Although basal cell carcinoma (BCC) is one of the most prevalent cancers in the U.S., locally advanced or metastatic BCC was reported to be less than 1% of the cases in a commercially insured U.S. population. Neurological symptoms are rarely reported in association with BCC; however, unt...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691966/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.156 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|